Philanthropies Commit to AI for Global Health

- This initiative, called Evidence for AI in Health (EVAH), is the second investment under a larger US$300 million, three-year partnership between the three philanthropies announced in 2024. The broader collaboration targets global health R&D to address the health impacts of climate change, infectious diseases like antimicrobial resistance (AMR), and the relationship between nutrition, immunity, and disease. - A key challenge the initiative aims to address is the lack of high-quality, localized data in low- and middle-income countries (LMICs), which is essential for training and validating AI algorithms. Many existing AI models are trained on data from developed countries and may not perform accurately in different demographic or disease contexts. - The project emphasizes local leadership and evaluation to ensure the AI tools are relevant and trusted by the communities they are intended to serve. Globally, a majority of countries have no specific policies or frameworks governing the use of AI in their health sectors, making localized evidence crucial for informed policymaking. - Beyond technological hurdles, successful AI implementation in LMICs must overcome significant infrastructure and workforce challenges, including unreliable power, limited computing resources, and a shortage of trained personnel to develop and manage AI systems. - This funding is part of a broader trend of "Grand Challenges" grants, a network of partners that has invested US$1.6 billion across 3,800 grants in 118 countries to foster innovation in solving key global health and development problems. - While AI holds the promise of improving diagnostics and streamlining healthcare, experts caution about potential risks, including the exacerbation of health disparities if not designed inclusively, and the ethical challenges of data privacy and algorithmic bias.